Mazars sponsors for the 3rd consecutive year the European Small and Mid-Cap Awards

The awards showcase the diversity of European markets, and aims to promote stock listings by targeting SMEs and growth companies. These companies are critical to European economic recovery and meeting the EU’s objective for job creation, competitiveness and growth.

The event will take place on November 22nd in Brussels, during Europe's Invest Week..

Between the nominees there are two Spanish companies:  CLEVER Global y Pangaea Oncology.

The nominees for this year's awards are the following companies:


International Star

ABEO is a strong and fast-growing company with turnover of €167 million for the year ended 31 March 2017, 70% of which is generated outside France. It boasts a portfolio of prominent brands in the world of sports and leisure (Gymnova, Janssen-Fritsen, Spieth, Entre-prises, Clip’nClimb, France Equipement, etc.) that are featured at major sporting events, including the Olympic Games. ABEO is listed on Euronext.          


CLEVER Global is a spanish multinational company that provides technological and SmartSourcing services specialising in procurement management and the control process for contractors, subcontractors, employees, machinery and vehicles. The company currently has presence in 54 countries worldwide with 12 established subsidiaries in Latin America, Europe and the Middle East. CLEVER Global is listed on MAB - BME.

Songa Bulk ASA was founded in 2016 by the Blystad Group and Mr. Herman Billung. Songa Bulk seeks to actively manage the cyclicality in dry bulk through investing at historically low asset values. The Company`s headquarters are located in Oslo, Norway. As per today's date, Songa Bulk has acquired 14 quality dry bulk vessels at historically low values over the last 10 months. Songa Bulk is listed on Oslo Børs.

Rising Star

Induct: Based on eitght years of collaboration with over 250 organisations, Induct offers innovation communities, delivered as "Software as a Service," that enable organisations to create, manage, track and measure the innovation process from idea creation through to final implementation and impact reporting. Induct enables its customers to connect with each other in larger networks to share best practices - all within a secure, collaborative, and access-controlled cloud-based network. Induct is listed on the Oslo Børs.


Pangaea Oncology is a medical services company, created in Barcelona, Spain, in 2007, focused on precision oncology, personalised medicine based on genetic analyses to improve survival and quality of life for cancer patients. Pangaea is highly invested in technology, focusing on the development of innovative, proprietary diagnostic techniques (its main commercialised asset is Liquid Biopsy), and development of targeted drugs - to early clinical trial stages. Pangaea Oncology is listed on MAB - BME.

Poulaillon is today an integrated family group in the baking, catering and snacking sectors with over 40 years of know-how and firmly established in Eastern France. Ever since the creation of the Moricette® in 1973, Poulaillon has continually innovated, offering a broad range of products that are marketed through its 45 sales outlets and through its large corporate clients. Poulaillon conducts business in France, Monaco, and Andorra. Poulaillon is listed on Euronext.

Star Innovation

Blue Prism is a pioneer and market leader in delivering Robotic Process Automation (“RPA”) software solutions. Blue Prism “invented” this new class of enterprise software in 2001. What makes Blue Prism so revolutionary is that it enables companies to create, deploy and manage their own “digital workforce” of software robots. Blue Prism is listed on the London Stock Exchange.    


CELLINK AB is the first bioink company in the world and a leading bioprinting company that focuses on developing technologies that allow researchers to print out human organs and tissues for the development of pharmaceutical and cosmetic treatments.  CELLINK AB is listed on Nasdaq.



Gentian Diagnostics is a medical diagnostics company. It designs, develops and markets in vitro diagnostic reagents (IVD) based on its proprietary NanosenseTM technology. The goal is to offer efficient and accurate reagents within the areas of kidney disease, cardiac disease, inflammation and veterinary medicine. Gentian Diagnostics is listed on the Oslo Børs.

Star of 2017

GARO develops, manufactures and supplies innovative products and systems for the electrical installations industry under its own brand. The company has operations in Sweden, Norway, Finland, Ireland and Poland and the Group is organized in two business segments GARO Sweden and GARO Other markets. GARO has a broad product assortment and is a market leader within several product areas. Garo is listed on Nasdaq.             


Hotel Chocolat is a premium British chocolatier with a strong and distinct brand. The business was founded in 1993 by Angus Thirlwell and Peter Harris and has traded under the Hotel Chocolat brand since 2003. The Group sells its products online and through a network of stores in the UK and abroad. The Group has two restaurants in the UK and a cocoa plantation and hotel in Saint Lucia. Hotel Chocolat is listed on the London Stock Exchange.

Kotipizza Group consists of Kotipizza Oyj, operating the pizza chain Kotipizza, Mexican-style restaurant chain Chalupa Oy, and logistics company Helsinki Foodstock Oy. The Group’s mission is to make the world a better place one pizza at a time. Established in 1987, Kotipizza is the largest pizza chain in the Nordics and one of Finland’s best-known restaurant brands. It currently has some 270 restaurants and 260 franchisees. KOTIPIZZA is listed on Nasdaq.

For more information or to register, please visit